FET-PET imaging (18F-fluoroethyltyrosine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FET-PET imaging (18F-fluoroethyltyrosine), covering 2012-08-07 to 2012-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients